Results 231 to 240 of about 34,150 (283)

Pentoxifylline adjunct to risperidone for negative symptoms of stable schizophrenia: a randomized, double-blind, placebo-controlled trial. [PDF]

Int J Neuropsychopharmacol
Shamabadi A, Rafiei-Tabatabaei ES, Kazemzadeh K, Farahmand K, Fallahpour B, Khodaei Ardakani MR, Akhondzadeh S.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial

International Clinical Psychopharmacology, 2021
In this randomized, double-blind, placebo-controlled clinical trial, we assessed the efficacy and safety of pentoxifylline combination therapy with sertraline in treatment of major depressive disorder (MDD).
Mostafa Farajollahi-Moghadam, Hossein Sanjari-Moghaddam, Maryam Ghazizadeh Hasemi, Zahra Sanatian, A. Talaei, S. Akhondzadeh   +5 more
semanticscholar   +1 more source

Pentoxifylline

Reactions Weekly, 2017
semanticscholar   +3 more sources

Pentoxifylline

Journal of the American Academy of Dermatology, 1994
Pentoxifylline (oxpentifylline) is a methylxanthine derivative with potent hemorrheologic properties. In the United States it is marketed for the treatment of intermittent claudication. Human and animal studies have shown that pentoxifylline therapy results in a variety of physiological changes at the cellular level, which may be important in treating ...
C P, Samlaska, E A, Winfield
openaire   +3 more sources

Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials.

Gastroenterology, 2018
BACKGROUND & AIMS We performed a meta-analysis of individual patient data from 11 randomized controlled trials comparing corticosteroids, pentoxifylline, or their combination in patients with severe alcoholic hepatitis.
A. Louvet, M. Thursz, D. J. Kim, J. Labreuche, S. Atkinson, S. Sidhu, J. O'grady, E. Akriviadis, E. Sinakos, R. Carithers, M. Ramond, W. Maddrey, T. Morgan, A. Duhamel, P. Mathurin   +14 more
semanticscholar   +1 more source

Efficacy of pentoxifylline–tocopherol–clodronate in mandibular osteoradionecrosis

The Laryngoscope, 2019
PENTOCLO treatment, associating pentoxifylline, tocopherol, and clodronate, resolves radiation‐induced fibrosis. The main aim of the present study was to prospectively assess efficacy in mandibular osteoradionecrosis (ORN).
A. Dissard, Nathalie P Dang, I. Barthélémy, C. Delbet, M. Puechmaille, A. Depeyre, B. Pereira, F. Martin, F. Guillemin, J. Biau, S. Mirafzal, T. Mom, L. Gilain, N. Saroul   +13 more
semanticscholar   +1 more source

Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease

Diabetes Care, 2018
OBJECTIVE The effect of pentoxifylline on Klotho levels in patients with type 2 diabetes mellitus with chronic kidney disease (CKD) was assessed in a post hoc analysis of the Pentoxifylline for Renoprotection in Diabetic Nephropathy (PREDIAN) trial ...
J. Navarro-González, M. Sánchez-Niño, J. Donate-Correa, E. Martín-Núñez, C. Ferri, N. Pérez-Delgado, J. Górriz, A. Martínez-Castelao, A. Ortiz, C. Mora-Fernández   +9 more
semanticscholar   +1 more source

Potential Use of Pentoxifylline in Cancer Therapy.

Current Pharmaceutical Biotechnology, 2018
BACKGROUND Pentoxifylline (PTX) is a drug commonly used in the treatment of intermittent claudication. However, numerous research groups report that PTX also may potentially be used in the anticancer therapy following one of the main trends in the ...
G. Gołuński, A. Woziwodzka, J. Piosik
semanticscholar   +1 more source